| Income Statement |
| Operating Expenses | 1.72M |
|
| Research and Development Expense | 59.00K |
| Selling, General and Administrative Expense | 1.66M |
| Operating Income | -1.72M |
| Net Income | -1.58M |
| Net Income Common Stock | -1.58M |
| Net Income Common Stock (USD) | -1.58M |
| Consolidated Income | -1.58M |
| Earnings per Basic Share | -21.32 |
| Earnings per Basic Share (USD) | -21.32 |
| Earnings per Diluted Share | -21.32 |
| Earning Before Interest & Taxes (EBIT) | -1.58M |
| Earning Before Interest & Taxes (USD) | -1.58M |
| Weighted Average Shares | 74.16K |
| Weighted Average Shares Diluted | 74.16K |
| Balance Sheet |
| Cash and Equivalents | 229.00K |
| Cash and Equivalents (USD) | 229.00K |
| Investments | 7.00M |
| Investments Current | 7.00M |
| Current Assets | 10.58M |
| Total Assets | 10.58M |
| Current Liabilities | 1.54M |
| Total Liabilities | 1.54M |
| Accumulated Retained Earnings (Deficit) | -698.10M |
| Shareholders Equity | 9.04M |
| Shareholders Equity (USD) | 9.04M |
| Trade and Non-Trade Payables | 1.14M |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.53M |
| Net Cash Flow from Operations | -1.53M |
| Share Based Compensation | -136.00K |